In-vitro diagnostic substance manufacturing - chromium next GEM-x single cell 3' kit V4, 16 samples (1000691)

Ended Awarded Last action

Contract number
75N95D25F40037
Awardee
Awarding agency
Obligated
$22,607

Award facts

Contract value 100% obligated
$22,606.67 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Pleasanton, CA 94588, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 · FY26 UDO initiative - in-vitro diagnostic substance manufacturing - chromium next GEM-x single cell 3' kit V4, 16 samples (1000691) $0
Original award $22,607

About this award

The National Institute on Aging has issued a delivery order to 10X Genomics, Inc. valued at $22,606.67 for in-vitro diagnostic substance manufacturing of Chromium Next GEM-X Single Cell 3' Kit V4 consumables, specifically 16 samples. This firm fixed price delivery order, awarded September 19, 2025, with an ultimate completion date of October 20, 2025, supports the FY26 Unlocking Diversity Onward (UDO) Initiative and will be performed at the vendor's facility in Pleasanton, California. The award carries no set-aside designation and represents a task order issued under 10X Genomics' existing $7 million single-award indefinite delivery contract with the NIA through July 2029, which provides genomic analysis platforms, reagent kits, and related consumables to support the Institute's research into neurological diseases and age-related disorders.

10X Genomics, a leading biotechnology company specializing in single-cell and spatial transcriptomics technologies, has been a registered federal contractor since 2015 and maintains substantial contractual relationships across multiple National Institutes of Health components. The Chromium Next GEM-X Single Cell Kit represents a core product offering within the company's portfolio of advanced genomic analysis tools that enable high-resolution molecular research critical to modern biomedical investigation. This particular delivery order aligns with the NIA's sustained utilization of 10X Genomics' specialized products to investigate complex biological systems and support cutting-edge molecular research infrastructure across federal research facilities.

Quick answers

Who was awarded contract 75N95D25F40037?

75N95D25F40037 was awarded to 10X Genomics, Inc. by National Institute on Aging (National Institutes of Health) on September 19, 2025.

How much is contract 75N95D25F40037 worth?

The government has obligated $22,607 on 75N95D25F40037.

Is contract 75N95D25F40037 an order under another contract?

Yes. 75N95D25F40037 is a delivery order under 75N95024D00029, an indefinite delivery contract.

Was contract 75N95D25F40037 competed?

The extent of competition for 75N95D25F40037 was competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award